Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01548352 · ClinicalTrials.gov registry record
BAsel Syncope EvaLuation (BASEL IX) Study
A clinical trial of Syncope, sponsored by University Hospital, Basel, Switzerland.
- Active
- Registry status
- 3,500
- Enrollment target
- 15
- Study locations
NCT01548352 is a study of Syncope that is active but no longer recruiting, run by University Hospital, Basel, Switzerland. The registered enrollment target is 3,500 participants, above the 533-participant average among 11 other Syncope trials with a reported enrollment target (557% higher). The trial reports 15 study locations across 5 states.
The verdict
NCT01548352, a study of Syncope, is active but no longer recruiting, sponsored by University Hospital, Basel, Switzerland.
- ACTIVE NOT RECRUITING
- Registry status
- 3,500 participants
- Enrollment target
- 15
- Study locations
Study Summary
Syncope is a major health problem. In the emergency department (ED), the management of patients with syncope still remains a clinical challenge because underlying diseases and prognosis can be extremely various. Structural heart disease and primary electrical disorders are major risk factors for sudden cardiac death and mortality in patients with syncope. In contrast, patients with reflex syncope and exclusion of structural heart disease have an excellent prognosis. Therefore The investigators test the hypothesis that the use of a meticulous patient history, clinical examination and novel biomarkers can improve the rapid and accurate diagnosis of cardiac syncope in patients presenting to the ED and is able to improve risk stratification regarding adverse outcomes. The prospective multicenter cohort study is designed to enroll 720 patients presenting with transient loss of consciousness within the last 12 hours to the ED. Blood samples for the measurement of novel biomarkers will be obtained at presentation. All patients will be contacted by phone at 6, 12 and 24 months to determine major adverse events (death, resuscitation, recurrence of syncope, hospitalization for syncope).
Conditions Studied
Study Locations (15)
Other
- Instituto Cardiovascular de Buenos Aires - Buenos Aires
- Royal Brisbane and Women's hospital - Brisbane
- Sant'Andrea Hospital - Rome
- Christchurch Hospital - Christchurch
- Medical University of Silesia - Zabrze
- Hospital del Mar - Barcelona
- Hospital Clinic of Barcelona - Barcelona
- Hospital Universitario Clínico San Carlos - Madrid
- University Hospital Basel - Basel
- Luzern Kantonsspital - Lucerne
- University Hospital Zurich - Zurich
Texas
- Baylor College of Medicine - Houston
Bavaria
- Klinikum Nürnberg - Nuremberg
Basel-Landschaft
- Kantonsspital Baselland - Liestal
Canton of Schwyz
- Spital Lachen - Lachen
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,500 participants |
| Start Date | 2010-04 |
| Est. Completion | 2025-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01548352
The ClinicalTrials.gov registry entry for NCT01548352 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 3,500 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 533-participant average among 11 other Syncope trials with a reported enrollment target (557% higher). The listed sponsor is University Hospital, Basel, Switzerland, which has 12 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Syncope appearing as the primary indexed condition, and to 0 interventions.
NCT01548352 reports 15 study locations spanning 5 distinct geographic areas - top geographies include Other, Texas, Bavaria.
Frequently Asked Questions
What is clinical trial NCT01548352 about?
NCT01548352 is a clinical study titled "BAsel Syncope EvaLuation (BASEL IX) Study". Syncope is a major health problem. In the emergency department (ED), the management of patients with syncope still remains a clinical challenge because underlying diseases and prognosis can be extremely various. Structural heart disease and primary electrical disorders are major risk factors for sud...
What is the current status of trial NCT01548352?
This trial is currently active not recruiting. The enrollment target is 3,500 participants. The study started on 2010-04. Estimated completion is 2025-12.
What conditions does trial NCT01548352 study?
This clinical trial studies the following conditions: Syncope.
Who is sponsoring clinical trial NCT01548352?
This trial is sponsored by University Hospital, Basel, Switzerland, which has 12 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01548352 being conducted?
This trial has 15 study locations across Texas, Bavaria, Basel-Landschaft, Canton of Schwyz. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Syncope
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
The Z Stitch Early Bed Rest Assessment Study
RECRUITING · NA
-
Genetic Markers of Cardiovascular Disease in Epilepsy
RECRUITING
-
Pediatric Adhesion and New Dermal Approach Study
ACTIVE NOT RECRUITING · NA
-
Quasi-Randomized Evaluation of the UCLA Next Day Clinic (NDC)
ACTIVE NOT RECRUITING · NA
-
Propranolol to Treat Fainting in Children With Sympathoadrenal Imbalance
COMPLETED · Phase 2
-
Practical Approaches to Care in Emergency Syncope
COMPLETED
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.